Portolan Capital Management, LLC Maxcyte, Inc. Transaction History
Portolan Capital Management, LLC
- $1.13 Billion
- Q2 2024
A detailed history of Portolan Capital Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 1,687,650 shares of MXCT stock, worth $6.53 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
1,687,650
Previous 1,721,777
1.98%
Holding current value
$6.53 Million
Previous $7.21 Million
8.3%
% of portfolio
0.59%
Previous 0.56%
Shares
6 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
65MCall Options Held
600Put Options Held
2.7K-
Black Rock Inc. New York, NY8.14MShares$31.5 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY7.62MShares$29.5 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$21.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$20 Million0.01% of portfolio
-
Vitruvian Partners LLP5.04MShares$19.5 Million5.8% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $394M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...